121 related articles for article (PubMed ID: 16352662)
1. Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way.
Lerdrup M; Hommelgaard AM; Grandal M; van Deurs B
J Cell Sci; 2006 Jan; 119(Pt 1):85-95. PubMed ID: 16352662
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent.
Pedersen NM; Madshus IH; Haslekås C; Stang E
Mol Cancer Res; 2008 Mar; 6(3):491-500. PubMed ID: 18337455
[TBL] [Abstract][Full Text] [Related]
3. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
4. Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells.
Castagnola P; Bellese G; Birocchi F; Gagliani MC; Tacchetti C; Cortese K
Oncotarget; 2016 Dec; 7(51):85411-85429. PubMed ID: 27863425
[TBL] [Abstract][Full Text] [Related]
5. Preubiquitinated chimeric ErbB2 is constitutively endocytosed and subsequently degraded in lysosomes.
Vuong TT; Berger C; Bertelsen V; Rødland MS; Stang E; Madshus IH
Exp Cell Res; 2013 Feb; 319(3):32-45. PubMed ID: 23127513
[TBL] [Abstract][Full Text] [Related]
6. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
8. Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.
Lerdrup M; Bruun S; Grandal MV; Roepstorff K; Kristensen MM; Hommelgaard AM; van Deurs B
Mol Biol Cell; 2007 Sep; 18(9):3656-66. PubMed ID: 17626164
[TBL] [Abstract][Full Text] [Related]
9. OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.
Tat SK; Padrines M; Theoleyre S; Couillaud-Battaglia S; Heymann D; Redini F; Fortun Y
Bone; 2006 Oct; 39(4):706-15. PubMed ID: 16750945
[TBL] [Abstract][Full Text] [Related]
10. ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.
Marx C; Held JM; Gibson BW; Benz CC
Cancer Res; 2010 May; 70(9):3709-17. PubMed ID: 20406983
[TBL] [Abstract][Full Text] [Related]
11. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.
Xu W; Yuan X; Xiang Z; Mimnaugh E; Marcu M; Neckers L
Nat Struct Mol Biol; 2005 Feb; 12(2):120-6. PubMed ID: 15643424
[TBL] [Abstract][Full Text] [Related]
12. The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments.
Cortese K; Howes MT; Lundmark R; Tagliatti E; Bagnato P; Petrelli A; Bono M; McMahon HT; Parton RG; Tacchetti C
Mol Biol Cell; 2013 Jan; 24(2):129-44. PubMed ID: 23154999
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites.
Lee K; Ryu JS; Jin Y; Kim W; Kaur N; Chung SJ; Jeon YJ; Park JT; Bang JS; Lee HS; Kim TY; Lee JJ; Hong YS
Org Biomol Chem; 2008 Jan; 6(2):340-8. PubMed ID: 18175003
[TBL] [Abstract][Full Text] [Related]
14. Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2.
Hashizume T; Fukuda T; Nagaoka T; Tada H; Yamada H; Watanabe K; Salomon DS; Seno M
Cell Biol Int; 2008 Jul; 32(7):814-26. PubMed ID: 18442934
[TBL] [Abstract][Full Text] [Related]
15. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK).
Qing G; Yan P; Xiao G
Cell Res; 2006 Nov; 16(11):895-901. PubMed ID: 17088896
[TBL] [Abstract][Full Text] [Related]
16. Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells.
Barr DJ; Ostermeyer-Fay AG; Matundan RA; Brown DA
J Cell Sci; 2008 Oct; 121(Pt 19):3155-66. PubMed ID: 18765569
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C mediated internalization of ErbB2 is independent of clathrin, ubiquitination and Hsp90 dissociation.
Dietrich M; Malik MS; Nikolaysen F; Skeie M; Stang E
Exp Cell Res; 2018 Oct; 371(1):139-150. PubMed ID: 30098331
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury.
Gabrielson K; Bedja D; Pin S; Tsao A; Gama L; Yuan B; Muratore N
Cancer Res; 2007 Feb; 67(4):1436-41. PubMed ID: 17308081
[TBL] [Abstract][Full Text] [Related]
19. Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells.
Carelli S; Di Giulio AM; Paratore S; Bosari S; Gorio A
J Cell Physiol; 2006 Aug; 208(2):354-62. PubMed ID: 16619240
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity.
Mimnaugh EG; Xu W; Vos M; Yuan X; Isaacs JS; Bisht KS; Gius D; Neckers L
Mol Cancer Ther; 2004 May; 3(5):551-66. PubMed ID: 15141013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
